CardiAQ Valve Technologies (CVT) Offers New Hope for Cardiovascular Medicine

6/19/2012 7:40:17 AM

Nearly 50% of patients suffering from a diseased mitral heart valve with severe, symptomatic regurgitation are denied open-heart surgery because it is considered too risky; in the future, Transcatheter Mitral Valve Implantation (TMVI) may offer new hope for these patients.

Read at Medical News Today

Read Article at

Related Companies

News Categories

• Medical News Today

• CardiAQ Valve Technologies (CVT)

• Medical Devices

• Medical Dev. & Diag. - Research